BioCurex, Inc.(fka BOCX)

[Kag]

Erthang,
This is well beyond proof of concept. It also appears to be beyond Abbott's "feasibility review", whatever that may be. BioCurex has designed a new colorimetric formated test that will run on most automated analyzers such as Abbott's c8000 Architect. That is one of the analyzers that is used to run rapid drug tests for substance abuse. BioCurex not only has proof that the serum RECAF technology works, but BioCurex also has developed a new assay format that is directly compatible with many of the larger diagnostic company's automated analyzers such as Abbott's c8000 Architect or Bayer's Advia 1200. Both of those analyzers presently can run approximately 600 to 800 colorimetric formatted assays per hour. kag